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Lesions of the ascending cholinergic pathway from nucleus basalis are known to have profound effects on cortical function. In particular, a sub- 
stantial potentiation of carbachol-stimulated polyphosphoinositide turnover is detected from 1 day after lesion and is maintained for several days 
before returning to normal by 1 month. In this study the effect of this lesion was investigated on levels of three G-protein a-subunit mRNAs. 
Excitotoxin lesion of the nucleus basahs caused a selective reduction in the levels of Qa mRNA in cerebral cortex i&lateral to the lesion, Gp 
and Gia mRNA being urn&e&d. The maximal effect was obtained at 3 days after lesion where levels of G,a mRNA were decreased by 4Q% com- 
pared to sham-operated animals. Levels of G,a mRNA returned to normal values by 28 days. Treatment with MK-SD1 caused a significant attenua- 
tion of the decrease in Gp mRN& indicating the involvement of NMUA m~ept5rs in this response. 
G-protein; Nucleus basal&; Cerebral cortex; Messenger RNA, MK-801; ~-me~yl-~asp~tate receptor 
1. INTRODUCTION 
Membrane transduction systems in the nervous 
system demonstrate considerable adaptation in 
response to a number of influences such as drug ad- 
ministrations hormone levels and ageing. In recent 
studies we have cbaraeterised aresponse to injury which 
is associated with an increased postsynaptic respon- 
siveness f1,2] and is not directly correlated with a 
change in receptor number or affinity [3]. In this study 
we have investigated whether an altered level of expres- 
sion of guanine nucleotide binding proteins (G- 
proteins) may be involved in mediating this effect. 
Increased carbachol responsiveness arises in the 
cerebral cortex after lesion of the afferent cholinergic 
pathway from nucleus basalis [1,2,4]. Excitotoxin injec- 
tion into nucleus basalis which lies in the basal 
forebrain gives rise to a substanti~ cholinergic deficit in 
cerebral cortex with decreases of up to 70% in the level 
of a~tyl~holinesterase (AChE) and the de~l~isation- 
induced release of acetylcho~n~ (ACh) [3,5]. Early 
changes occur after the lesion in the level of expression 
of, initially, c-fos mRNA and later ornithine decarbox- 
ylase (ODC) mRNA and enzyme activity which are 
maximal within 8 h of lesion, in common with other 
responses to injury in the nervous system [6-81. A later 
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response which is first detectable at 24 h and maximal 
at 3-10 days is an increase in cholinergic responsiveness 
which is detected as an increased polyphosphoinositide 
(PPI) response to stimulation with carbachol. The max- 
imal response increases 100% with no change in affinity 
of muscarinic receptor subtypes and a net decrease in 
muscarinic receptors [l-4]. The increased respon- 
siveness represents apotential mechanism for overcom- 
ing the cholinergic deficit. Later, ‘sprouting’ of spared 
axons occurs with a partial reversal of the cholinergic 
deficit and the increased PPI responsiveness. In view of 
the importance of G-proteins in the transduction of 
muscarinic receptor-mediated response, we have in- 
vestigated the expression of three G-protein o-subunit 
mRNAs at various times after lesion of the nucleus 
basalis, Further, in view of the observations that both 
changes in c-fos and ODC mRNA and PPI respon- 
siveness are highly sensitive to treatment with the N- 
methyl-D-aspartate (NMDA) glutamate receptor an- 
tagonist, MK-801, we have examined the effect of this 
agent on the expression of G-protein mRNAs. 
2. MATERIALS AND METHODS 
Male CFY rats (wt. 250 -c 25 g at time of surgery) were anaesthetiz- 
ed with Sagatal (pentobarbitone) at a dose of 90-100 mg/kg and plac- 
ed in a stereotaxic frame. Unilateral lesion of the right nucleus basalis 
was carried out by injection of the excitotoxin; kainatc (1 pg in 0.5 ~1 
saline, pH 7.0) into the nucleus basalis (co-ordinates: AP + 1.2, 
late& + 2.1, with respect o bregma: incisor bar at 5 mm above the 
intra-aural line) at a depth of 8 mm below the skull surface over a 
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period of 1 min [3]. The needle was left in place for 5 min to reduce 
refiux of kainate. Sham-operated animals were treated as above, but 
using saline vehicle for injection. 
Rats were sacrificed by stunning and cervical dislocation at 1, 3, 7 
and 28 days after kainate injection. Frantoparietai cortex ipsilateral 
and contralateral to the site of injection and cerebral cortex, caudate 
and liver from uuoperated animals were dissected, frozen immediate- 
ly in liquid nitrogen and stored at -70°C until required. 
Totaf RNA was isolated from tissue sampies by acid guanidinium 
~~iocyanate~phenol~chlorofo~ extraction 191. The resulting RNA 
was analysed by Northern blotting and slot blotting as previously 
described [7] I
The following probes were used to detect G-protein a-subunit 
mRNAs on Northern and slot blots: a 1.7 kb EcoRf fragment of 
pGIl3 derived from a CRNA sequence ncoding for Gia; a 1.2 kb 
EcoRl fragment of pGI23 derived from a cDNA sequence coding for 
Cool and a 1.1 kb fragment of pGI 11L derived from a cDNA sequence 
coding for Gso. All cDNAs were isolated from the rat C6 glioma cell 
line [ 101 and were kindly donated by Dr ltoh. An 800 bp cDNA frag- 
ment of @-tubulin, derived from a human foetal brain library Ill], 
was used as a reference probe, 
Northern blot filters were me-incubated in hybridisation buffer 
(50% formamide, 5 x SSPE (0.9 M NaCl, 0.05 M sodium phosphate, 
pH 7.4, 5 mM EDTA), 5 x Denhardt’s olution (0.1% bovine serum 
albumin, 0.1% Ficoll, 0.1 cr/, po~~nylp~olidone~, 0.5% (w/v) 
sodium dodecyl sulphate, 100 pgdml salmon sperm DNA} for 2 h at 
42°C. Filters were then hybridised overnight at 4Z°C in hyb~d~sat~on 
buffer containing 5-7 x IO’ dpm Iabelled to a specific activity of 
2.5-3.5 x IO9 dpm/pg with [cx-“P]dCTP using the oligolabelling 
method of Feinberg and Vogelstein 112,131. Blots were washed with 
1 x SSC, 0.1 To SDS for 30 min at 65°C followed by 0.1 x SSC, 0.1% 
SDS for 30 min at 65°C and exposed to pre-flashed Hyperfilm-MP 
(Amersham International PLC) with intensifying screens for 72 h at 
- 7o”c. 
Quantitation of G-protein a-subunit mRNA levels relative to fl- 
tubulin mRNA levels was carried out by slat blot analysis as follows: 
slot blot fiiters were hybridised with each [32P]cDNA and then washed 
and autoradiographed as described above. Duplicate dot blot filters 
were hybridised with f3’Pf&tubulin cRNA as described above, then 
washed with 1 x SSC, 0.1 %I SDS for 30 min at 65OC followed by 0.1 
x SSC, 0.1% SDS for 30 min at 65°C and autora~o~aph~ as 
described above. 
The intensity of hybridisation on slot blots was measured with a 
scanning densitometer (Joyce Loebl Chromoscan) at 530 nm. Results 
are expressed as a ratio of the G-protein mRNA signal : P-tubulin 
mRNA signal. Statistical analysis was carried out using the Student’s 
t-test. 
3. RESULTS 
3.1. Nurthern blot analysis uf G-protein atsubunit 
&WAS in moperated animals 
G-protein mRNAs were initially characterised in 
cerebral cortex, caudate nucleus and liver from 
unuperated animals, Northern blot analysis revealed 
major bands of 2-U kb, 2.4 kb and 4.5 kb for Gs~, Gia 
and GOcr mRNAs, respectively (Fig. 1). These sizes are 
consistent with those reported previously [14]. In this 
study GOcr mRNA was found only in neuronal tissue 
and was not detectable in liver. 
3.2. Effect of unila#erai kainate injection on G-protein 
a-subunit mRNAs at 3 days 
Levels of the three G-protein a-subunit mRNAs were 
initially examined at 3 days after unilateral injection of 
kainate into the nucleus basalis as this is a period during 
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Fig. 1. Northern blot analysis of G-protein a-subunit mRNAs isolated 
from cerebral cortex, caudate and liver. Northern blots of RNA (20 
irg/track) isolated from cerebral cortex (0x1, caudate (Ca) and liver 
(Li) of control animals were hybridised with (a) [3’P]Gio-cDNA (Gil, 
(b) 13’P]Go~-cDNA, and (c) [“PIG,-cDNA. 
which a maximal increase in PPI responsiveness i ob- 
tained [2]. RNA was isolated from cerebral cortex ip- 
silateral and contralateral to the kainate injection at 3 
days and from unoperated animals. Levels of Giar, GOcr 
and Gsar mRNA were quantitated relative to @-tubulin 
mRNA levels by slot blot analysis. A significant 
decrease af 64% in the levei of G0a mRNA in ipsilateral 
cerebral cortex was ubserved at 3 days after kainate in- 
jection compared with contralateral cortex (P c 0.001) 
and of 42?7@ when compared to the equivalent 
hemisphere from unoperated animals (P < 0.001) (Fig. 
2). Levels of Giti mRNA or G,CY mRNA in kainate in- 
jected animals were not significantiy different from 
those in unoperated animals. These results indicate that 
Gocr mRNA is specifically reduced in response to 
unilateral kainate injection at 3 days. 
3.3. Time course of changes in GQa mRNA 
The time course of changes in the level of GOtr mRNA 
was studied by slot blot analysis for a period of up to 28 
days after kainate or vehicle injection into the nucleus 
basalis. The maximal decrease in G,CX mRNA was 
detected at 3 days after kainate injection where the level 
of G,a! mRNA in ipsilateral cortex as a ratio of that in 
contralateral cortex was significantly reduced by 40% 
(P < 0.005) compared to that in sham-operated 
animals in which vehicle only was injected into the 
nucleus basalis (Fig. 3). Thereafter levels of Gocv mRNA 
in ipsilateral cortex as a percentage of those in con- 
tralateral cortex returned to the baseline value by 23 
days after kainate injection. No significant effect of the 
lesion was detected at I day, The levels of GOcv mRNA 
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Fig. 2. Effect of unilateral kainate injection on G-protein a-subunit 
mRNAs. Slot blots of RNA isolated from ipsilateral (lesion) and con- 
tralateral (control) cerebral cortex at 3 days after unilateral kainate in- 
jection and from the equivalent hemispheres (left (L) and right (R)) of 
unoperated animals were hybridised with [32P]Gio cDNA (Gi), [3zP]- 
Gocz cDNA (Go) and [3ZP]Ga~ cDNA (Gs). Levels of G-protein mRNA 
are expressed relative to fl-tubulin mRNA levels. Results are means f 
SE for 5 animals in the unoperated groups and 7 animals in groups in- 
jected with kainate. *Indicates that, at 3 days, unilateral kainate injec- 
tion into nucleus basalis caused a decrease in the level of G, mRNA 
in ipsilateral cerebral cortex compared with contralateral cortex (P < 
0.001) and compared with the equivalent hemisphere in unoperated 
animals (P < 0.001). 
in cerebral cortex of sham-operated animals in which 
vehicle only was injected into the nucleus basalis show- 
ed no significant changes relative to unoperated control 
animals. 
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Fig. 3. Time course of the effect of unilateral kainate injection on 
levels of Goal mRNA in cerebral cortex. G,,cY mRNA was measured in 
cerebral cortex at 1, 3, 7 and 28 days after injection of vehicle (sham) 
or kainate (lesion) into the nucleus basalis. Levels of G, mRNA were 
quantitated relative to levels of fi-tubulin mRNA by slot blot analysis. 
Results are expressed as levels of Go mRNA in cortex ipsilateral to the 
site of kainate injection as a percentage of levels of G, mRNA in con- 
tralateral cortex. Values are means f SE for 5 animals in all groups 
except for the groups of lesioned animals at 1, 3 and 7 days where n 
= 11. *Indicates that unilateral injection of kainate caused a signifi- 
cant decrease in G, mRNA in lesioned cortex compared with sham- 
operated animals in which vehicle only was injected into the nucleus 
basalis (P < 0.005). This result reflects a net decrease in the level of 
G, mRNA in ipsilateral cortex since the level in contralateral cortex 
at 3 days was not significantly different from that in either hemisphere 
of unoperated animals. However, at 7 days the level of Go mRNA in 
contralateral cortex was significantly increased by 24% (P c 0.040) 
compared with that in ipsilateral cortex. Hence the apparent decrease 
in the proportion of G,a mRNA in ipsilateral cortex actually reflects 
a slight increase in the level of G, mRNA in contralateral cortex at 7 
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Fig.4. Localisation of Go mRNA in cerebral cortex following 
unilateral injection of kainate into nucleus basalis. In order to deter- 
mine whether the decrease in the level of Go mRNA in ipsilateral cor- 
tex at 3 days was due to the excitation of the pathway by kainate injec- 
tion into the nucleus basalis, rather than due to non-specific tissue 
damage around the site of needle entry, G, mRNA was assayed in 
regions of cerebral cortex coinciding with areas receiving an innerva- 
tion from the nucleus basalis. Levels of G, mRNA were quantitated 
relative to levels of @-tubulin mRNA in a strip of ipsilateral cerebral 
cortex in the immediate vicinity of the site of needle entry (central), 
in two strips of ipsilateral frontoparietal cortex immediately adjacent 
to this region (rostra1 and caudal) and in contralateral cerebral cortex 
at 3 days. Values are means * SE for 3 animals. * and ** indicate that 
unilateral injection of kainate caused a significant reduction in G, 
mRNA (P < 0.014 and P < 0.001, respectively) in all three regions 
of ipsilateral cerebral cortex compared with contralateral cortex. 
Autoradiographs of representative slot blots loaded with x pg RNA 
probed with [32P]G,~ cDNA and [32P]P-tubulin cDNA are shown 
days. below the histograms. 
In order to confirm that the reduction in the level of 
G,,(Y mRNA in ipsilateral cerebral cortex was dependent 
on the activation of the ascending pathway from the 
nucleus basalis, and not due to local tissue damage 
around the site of needle entry, G,a! mRNA was 
measured in a strip of ipsilateral frontoparietal cortex 
in the immediate vicinity of the site of needle entry and 
in two strips of ipsilateral frontoparietal cortex im- 
mediately adjacent to this region. The level of Goo 
mRNA was significantly reduced in all three of these 
regions compared to contralateral cortex at 3 days (Fig. 
4). Since these regions coincide with the area of innerva- 
tion from the nucleus basalis, the reduction in G,,cY 
mRNA is likely to be initiated by kainate-induced ex- 
citation of this ascending pathway. 
3.4. Effect of MK-801 on the level of G,,cx mRNA in 
cerebral cortex in response to kainate injection 
into the nucleus basalis 
The NMDA receptor antagonist MK-801 was tested 
for its effect on the G,CY mRNA response to unilateral 
kainate injection at 3 days. At a dose of 1 mg/kg, 
MK-801 administered 2 h after unilateral kainate injec- 
tion, significantly attenuated the reduction in GOcr 
65 
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Table I 
Effect of MK-801 on the reduction of Go mRNA levels in cerebral cor- 
tex in response to unilateral injection of kainate into nucleus basalis 
G, mRNA in cerebral cortex ipsilateral to 
kainate injection (vo contralateral cortex) 
Sham 95.4 f 13.5 
Vehicle 51.0 + 5.8 
MK-801 (1 mg/kg) 79.4 + 8.9* 
MK-801 at a dose of 1 mg/kg or vehicle (5% ethanol) was ad- 
ministered i.p. at 2 h after kainate injection into nucleus basal&. 
Results are expressed as the ratio of G, mRNA/~-tubulin mRNA in 
the ipsilateral cortex as a percentage of the ratio of G, mRNA@- 
tubulin mRNA in contralateral cortex. Values are means It SE for 5 
animals in each group. *Indicates that MK-801 significantly at- 
tenuated the reduction in G,or mRNA in cerebral cortex compared 
with vehicle treated animals (P < 0.029). 
mRNA seen at 3 days by 64% (P < 0.029) (Table I). 
This result indicates that a major component of the 
reduction in G,a! mRNA in ipsiiateral cerebral cortex is 
mediated by NMDA receptors. 
4. DISCUSSION 
G-Proteins are abundant in the nervous system, in 
keeping with the importance of transduction 
mechanisms in neuronal communication. Eight G- 
protein genes have been identified by molecular cloning 
of cDNAs and the three G-proteins which are most 
abundant in the mammalian brain, G,, Gi and G,, have 
been extensively characterised [IO]. They are composed 
of three subunits, cy, P and y. The cr subunit contains 
the guanine nucleotide binding site and the same /3 and 
7 subunits are common to many G-proteins. The 
molecular sizes of the rx subunits are 45,41 and 39 kDa 
for the G,, Gi and G, subunit, respectively. The G,ar 
subunit directly activates adenylate cyclase and is ADP 
ribosylated by cholera toxin. The Gio subunit inhibits 
adenylate cyclase and both and Gio and Goo can be 
ADP-ribosylated by pertussus toxin in certain systems. 
G~CY and G,a! are also thought to have a direct effect on 
phospholipase C, K+ -channel gating and voltage- 
dependent calcium channels. The distribution of a! 
subunit mRNAs in the mammalian brain has been 
characterised by in situ hybridisation, G,, Gr2 and G, 
being more abundant than Gii and localised especially 
in regions such as cerebral cortex 1141, hip~campus 
and cerebellum. G, differs from Gs and Gi2 in that it is 
mainly localised to brain whereas G, and Gi2 are also 
abundant in other tissues. G-Proteins are involved in 
the three main responses of muscarinic receptors, in- 
hibition of adenylate cyclase, opening of K+ channels 
and the activation of phospholipase C which is affected 
in the experimental model investigated in the present 
study. Muscarinic agonist stimulation of PPI hydrolysis 
in rat cerebral cortex shows similar characteristics to 
that occurring in other tissues and G-protein involve- 
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ment is indicated since guanosine 5 ’ -@imido)- 
triphosphate (pfNH]ppG) and guanosine 5 ’ -(y-thio)- 
triphosphate (GTP(S]) potentiate the hydrolysis [ 1 S]. 
In this study, we have shown that lesion of the 
nucleus basalis causes a significant decrease in the level 
of G,cl! mRNA in cerebral cortex. The effect is specific 
for this o-subunit and no similar change occurs in the 
expression of Gia! and G,a mRNAs. This effect also has 
a similar time course to that shown for the increased 
PPI responsiveness and is transient in nature, decreas- 
ing to control levels by 1 month. Although a direct link 
between the decrease in GOlr and the increased PPI 
responsiveness has not yet been demonstrated, it might 
be speculated that G,cr mediates an inhibitory regula- 
tion of PPI responsiveness. Although G, is extremely 
abundant in the cerebral cortex its precise function has 
not yet been elucidated. However, studies on Xenopus 
oocytes indicate that G,o couples muscarinic receptors 
to PPI turnover [16] and an effect on voltage- 
dependent calcium channels has also been recently 
demonstrated. Noradrenaline, dopamine and y- 
aminobutyric acid (GABA) inhibit the voltage- 
dependent calcium channel in dorsal root and sym- 
pathetic ganglia, which effect can be mimicked by in- 
tracellular guanine nucleotides and blocked by pertussis 
toxin. A similar effect can be demonstrated with opioid 
peptides in neuroblastoma cells where it has been 
specifically shown that the pertussis toxin block can be 
prevented by intracellular application of Gi and G,, the 
latter effect of G, being 10 times more potent than Gi 
[17]. This is further supported from the evidence that 
rat brain G, is a substrate of pertussis toxin ADP- 
ribosylation [ 181. The loss of an inhibitory regulation 
mediated through G, which enhances calcium entry 
would facilitate PPI responses since depol~isation 
which induces Ca2 + entry is known to activate PPI 
turnover [19]. Hence the temporary suppression of G, 
function would promote cholinergic action over the 
period when cholinergic function is depressed. 
The nature of possible intermediary processes in- 
itiating a change in G, expression is indicated from the 
effect of treatment with MK-801. Although treatment 
with MK-801 does not modify the neurotoxic effect of 
kainate on nucleus basalis cells and hence the subse- 
quent development of a cholinergic deficit in cerebral 
cortex, this treatment does prevent the induction of c- 
fos and ODC mRNA and the increased posts~aptic 
responsiveness [2,6,7]. Thus a clear association is seen 
between the latter process and the decrease in the level 
of Go mRNA seen here, indicating the involvement of 
an NMDA receptor in both processes. The NMDA 
receptor is directly linked to a cation channel and the 
mechanisms through which NMDA receptor activation 
could affect Go expression are likely to involve in- 
tracellular events induced by NMDA receptor activa- 
tion, e.g. Ca 2 + flux. Injection of rat brain mRNA into 
Xenopus oocytes has shown evidence of coupling of the 
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metabotropic glutamate receptor, which is activated by 
glutamate or quisqualate, to a G-protein 1201 and this 
system may well be activated’ during the excitatory 
phase induced by kainate injection. 
These results indicate that a selective and transient 
change can occur in response to a lesion of the nervous 
system and suggest that regulation of G-protein expres- 
sion offers a sensitive mechanism for a potentially 
useful adaptation. A differential regulation of Gsar and 
Gia mRNA and protein also occurs in brain after cor- 
ticosterone treatment with no effect on GOo mRNA 
[21], indicating a further example of an adaptive 
response depending on a specific regulation of G- 
protein expression. 
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